Back Login to subscribe 🔔 Set Alert

CANF Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares

15 min delay
Today's News Sentiment
Loading...
Upcoming Earnings
Loading...
CANF Fundamental Data
Loading...
Similar Companies
Loading...
CANF Options Chain
Put/Call Ratio
-
-
Expected Move
-
-
Max Pain
-
-
ATM Call Break-even
-
-
ATM Put Break-even
-
-
Loading options…
CALLS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
PUTS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
CANF Insider Transactions
Loading insider data…
CANF News
Date Headline Sentiment
Can-Fite BioPharma Announces New Preclinical Findings Demonstrating Namodenoson Enhances Anti-Cancer Effect Of Gemcitabine Chemotherapy In Pancreatic Cancer
80.42%
Can-Fite BioPharma Submits Phase 2 Clinical Study Protocol To Bambino Gesù Children's Hospital In Rome, Italy, For First Clinical Evaluation Of Piclidenoson In Patients With Lowe Syndrome
60.74%